Matches in SemOpenAlex for { <https://semopenalex.org/work/W2964549933> ?p ?o ?g. }
- W2964549933 endingPage "4142" @default.
- W2964549933 startingPage "4124" @default.
- W2964549933 abstract "Bruton’s tyrosine kinase (BTK) has emerged as an attractive target related to B-lymphocytes dysfunctions, especially hematologic malignancies and autoimmune diseases. In our study, a series of diphenylaminopyrimidine derivatives bearing dithiocarbamate moieties were designed and synthesized as novel BTK inhibitors for treatment of B-cell lymphoma. Among all these compounds, 30ab (IC50 = 1.15 ± 0.19 nM) displays similar or more potent inhibitory activity against BTK than spebrutinib (IC50 = 2.12 ± 0.32 nM) and FDA approved drug ibrutinib (IC50 = 3.89 ± 0.57 nM), which is attributed to close binding of 30ab with BTK predicted by molecular docking. In particular, 30ab exhibits enhanced anti-proliferative activity against B-lymphoma cell lines at the IC50 concentration of 0.357 ± 0.02 μM (Ramos) and 0.706 ± 0.05 μM (Raji), respectively, almost 10-fold better than ibrutinib and spebrutinib. In addition, 30ab displays stronger selectivity on B-cell lymphoma over other cancer cell lines than spebrutinib. Furthermore, 30ab efficiently blocks BTK downstream pathways and results in apoptosis of cancer cells. In vivo xenograft model evaluation demonstrates the significant efficacy and broad safety margin of 30ab in treatment of B-cell lymphoma. We propose that compound 30ab is a candidate for further study and development based on our current findings." @default.
- W2964549933 created "2019-08-13" @default.
- W2964549933 creator A5003115941 @default.
- W2964549933 creator A5053880675 @default.
- W2964549933 creator A5054280305 @default.
- W2964549933 creator A5060284538 @default.
- W2964549933 creator A5064263152 @default.
- W2964549933 creator A5064933759 @default.
- W2964549933 creator A5080072756 @default.
- W2964549933 creator A5086894930 @default.
- W2964549933 date "2019-09-01" @default.
- W2964549933 modified "2023-09-27" @default.
- W2964549933 title "Design, synthesis and biological evaluation of novel dithiocarbamate-substituted diphenylaminopyrimidine derivatives as BTK inhibitors" @default.
- W2964549933 cites W1142646448 @default.
- W2964549933 cites W1432871984 @default.
- W2964549933 cites W1533507997 @default.
- W2964549933 cites W1606843175 @default.
- W2964549933 cites W1993345471 @default.
- W2964549933 cites W1997513635 @default.
- W2964549933 cites W2005168850 @default.
- W2964549933 cites W2029365157 @default.
- W2964549933 cites W2030784296 @default.
- W2964549933 cites W2035536649 @default.
- W2964549933 cites W2067326042 @default.
- W2964549933 cites W2112134595 @default.
- W2964549933 cites W2172609141 @default.
- W2964549933 cites W2291446399 @default.
- W2964549933 cites W2415756477 @default.
- W2964549933 cites W2517102811 @default.
- W2964549933 cites W2518577288 @default.
- W2964549933 cites W2557833390 @default.
- W2964549933 cites W2562093910 @default.
- W2964549933 cites W2567410711 @default.
- W2964549933 cites W2571078282 @default.
- W2964549933 cites W2585831040 @default.
- W2964549933 cites W2595874083 @default.
- W2964549933 cites W2606558956 @default.
- W2964549933 cites W2611512307 @default.
- W2964549933 cites W2614486214 @default.
- W2964549933 cites W2725311896 @default.
- W2964549933 cites W2732017093 @default.
- W2964549933 cites W2757321613 @default.
- W2964549933 cites W2770616566 @default.
- W2964549933 cites W2772508026 @default.
- W2964549933 cites W2788356134 @default.
- W2964549933 cites W2788938118 @default.
- W2964549933 cites W2793234989 @default.
- W2964549933 cites W2803105592 @default.
- W2964549933 cites W2849668997 @default.
- W2964549933 cites W2884684376 @default.
- W2964549933 cites W2891335972 @default.
- W2964549933 cites W2900024262 @default.
- W2964549933 cites W2914687302 @default.
- W2964549933 cites W2945885245 @default.
- W2964549933 cites W2946529203 @default.
- W2964549933 cites W2946718470 @default.
- W2964549933 cites W2949435945 @default.
- W2964549933 cites W2950137600 @default.
- W2964549933 cites W2951800701 @default.
- W2964549933 cites W651641139 @default.
- W2964549933 cites W773739020 @default.
- W2964549933 doi "https://doi.org/10.1016/j.bmc.2019.07.043" @default.
- W2964549933 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31395509" @default.
- W2964549933 hasPublicationYear "2019" @default.
- W2964549933 type Work @default.
- W2964549933 sameAs 2964549933 @default.
- W2964549933 citedByCount "9" @default.
- W2964549933 countsByYear W29645499332020 @default.
- W2964549933 countsByYear W29645499332021 @default.
- W2964549933 countsByYear W29645499332022 @default.
- W2964549933 countsByYear W29645499332023 @default.
- W2964549933 crossrefType "journal-article" @default.
- W2964549933 hasAuthorship W2964549933A5003115941 @default.
- W2964549933 hasAuthorship W2964549933A5053880675 @default.
- W2964549933 hasAuthorship W2964549933A5054280305 @default.
- W2964549933 hasAuthorship W2964549933A5060284538 @default.
- W2964549933 hasAuthorship W2964549933A5064263152 @default.
- W2964549933 hasAuthorship W2964549933A5064933759 @default.
- W2964549933 hasAuthorship W2964549933A5080072756 @default.
- W2964549933 hasAuthorship W2964549933A5086894930 @default.
- W2964549933 hasConcept C1491633281 @default.
- W2964549933 hasConcept C150903083 @default.
- W2964549933 hasConcept C159654299 @default.
- W2964549933 hasConcept C16232356 @default.
- W2964549933 hasConcept C178790620 @default.
- W2964549933 hasConcept C185592680 @default.
- W2964549933 hasConcept C190283241 @default.
- W2964549933 hasConcept C202751555 @default.
- W2964549933 hasConcept C203014093 @default.
- W2964549933 hasConcept C207001950 @default.
- W2964549933 hasConcept C2777545050 @default.
- W2964549933 hasConcept C2777752497 @default.
- W2964549933 hasConcept C2777938653 @default.
- W2964549933 hasConcept C2778453870 @default.
- W2964549933 hasConcept C2778461978 @default.
- W2964549933 hasConcept C2779338263 @default.
- W2964549933 hasConcept C2779878957 @default.
- W2964549933 hasConcept C42362537 @default.